Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
PremiumPress ReleasesAxogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
1M ago
AxoGen’s Annual Meeting Decisions and Director Changes
PremiumCompany Announcements
AxoGen’s Annual Meeting Decisions and Director Changes
2M ago
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
PremiumPress Releases
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
2M ago
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
PremiumPress ReleasesAxogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
3M ago
AxoGen announces first surgical implants of Avive+ soft tissue matrix
PremiumThe Fly
AxoGen announces first surgical implants of Avive+ soft tissue matrix
3M ago
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
PremiumPress Releases
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
3M ago
AxoGen sees FY24 revenue $177M-$181M, consensus $178.85M
PremiumThe FlyAxoGen sees FY24 revenue $177M-$181M, consensus $178.85M
5M ago
AxoGen reports Q4 adjusted EPS (6c), consensus (10c)
PremiumThe Fly
AxoGen reports Q4 adjusted EPS (6c), consensus (10c)
5M ago
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
PremiumPress Releases
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100